001     141416
005     20240229105126.0
024 7 _ |a 10.1038/s41598-018-35058-3
|2 doi
024 7 _ |a pmid:30420756
|2 pmid
024 7 _ |a altmetric:51193535
|2 altmetric
037 _ _ |a DKFZ-2018-01922
041 _ _ |a eng
082 _ _ |a 600
100 1 _ |a Kesch, Claudia
|b 0
245 _ _ |a Correlation between genomic index lesions and mpMRI and 68Ga-PSMA-PET/CT imaging features in primary prostate cancer.
260 _ _ |a [London]
|c 2018
|b Macmillan Publishers Limited, part of Springer Nature
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1695981602_24403
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Magnetic resonance imaging (MRI) and prostate specific membrane antigen (PSMA)- positron emission tomography (PET)/computed tomography (CT)-imaging of prostate cancer (PCa) are emerging techniques to assess the presence of significant disease and tumor progression. It is not known, however, whether and to what extent lesions detected by these imaging techniques correlate with genomic features of PCa. The aim of this study was therefore to define a genomic index lesion based on chromosomal copy number alterations (CNAs) as marker for tumor aggressiveness in prostate biopsies in direct correlation to multiparametric (mp) MRI and 68Ga-PSMA-PET/CT imaging features. CNA profiles of 46 biopsies from five consecutive patients with clinically high-risk PCa were obtained from radiologically suspicious and unsuspicious areas. All patients underwent mpMRI, MRI/TRUS-fusion biopsy, 68Ga-PSMA-PET/CT and a radical prostatectomy. CNAs were directly correlated to imaging features and radiogenomic analyses were performed. Highly significant CNAs (≥10 Mbp) were found in 22 of 46 biopsies. Chromosome 8p, 13q and 5q losses were the most common findings. There was an strong correspondence between the radiologic and the genomic index lesions. The radiogenomic analyses suggest the feasibility of developing radiologic signatures that can distinguish between genomically more or less aggressive lesions. In conclusion, imaging features of mpMRI and 68Ga-PSMA-PET/CT can guide to the genomically most aggressive lesion of a PCa. Radiogenomics may help to better differentiate between indolent and aggressive PCa in the future.
536 _ _ |a 312 - Functional and structural genomics (POF3-312)
|0 G:(DE-HGF)POF3-312
|c POF3-312
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Radtke, Jan-Philipp
|b 1
700 1 _ |a Wintsche, Axel
|b 2
700 1 _ |a Wiesenfarth, Manuel
|0 P:(DE-He78)1042737c83ba70ec508bdd99f0096864
|b 3
700 1 _ |a Luttje, Mariska
|b 4
700 1 _ |a Gasch, Claudia
|b 5
700 1 _ |a Dieffenbacher, Svenja
|b 6
700 1 _ |a Pecqueux, Carine
|b 7
700 1 _ |a Teber, Dogu
|b 8
700 1 _ |a Hatiboglu, Gencay
|b 9
700 1 _ |a Nyarangi-Dix, Joanne
|b 10
700 1 _ |a Simpfendörfer, Tobias
|b 11
700 1 _ |a Schönberg, Gita
|b 12
700 1 _ |a Dimitrakopoulou-Strauss, Antonia
|0 P:(DE-He78)b2df3652dfa3e19d5e96dfc53f44a992
|b 13
700 1 _ |a Freitag, Martin
|0 P:(DE-He78)c420f6efccb409e1a287be027501a74c
|b 14
700 1 _ |a Duensing, Anette
|0 0000-0002-0168-4067
|b 15
700 1 _ |a Grüllich, Carsten
|b 16
700 1 _ |a Jäger, Dirk
|b 17
700 1 _ |a Götz, Michael
|0 P:(DE-He78)abd768f879e71d08068d48fabb7e96cf
|b 18
700 1 _ |a Grabe, Niels
|b 19
700 1 _ |a Schweiger, Michal-Ruth
|b 20
700 1 _ |a Pahernik, Sascha
|b 21
700 1 _ |a Perner, Sven
|b 22
700 1 _ |a Herpel, Esther
|b 23
700 1 _ |a Roth, Wilfried
|b 24
700 1 _ |a Wieczorek, Kathrin
|b 25
700 1 _ |a Maier-Hein, Klaus
|0 P:(DE-He78)33c74005e1ce56f7025c4f6be15321b3
|b 26
700 1 _ |a Debus, Jürgen
|b 27
700 1 _ |a Haberkorn, Uwe
|0 P:(DE-He78)13a0afba029f5f64dc18b25ef7499558
|b 28
700 1 _ |a Giesel, Frederik
|0 P:(DE-He78)5ca7e97b2769bb97f8c73431c6566b94
|b 29
700 1 _ |a Galle, Jörg
|b 30
700 1 _ |a Hadaschik, Boris
|b 31
700 1 _ |a Schlemmer, Heinz-Peter
|0 P:(DE-He78)3d04c8fee58c9ab71f62ff80d06b6fec
|b 32
700 1 _ |a Hohenfellner, Markus
|b 33
700 1 _ |a Bonekamp, David
|0 P:(DE-He78)ea098e4d78abeb63afaf8c25ec6d6d93
|b 34
700 1 _ |a Sültmann, Holger
|0 P:(DE-He78)7483734fd8ab316391aa604c95f0e98a
|b 35
|e Last author
700 1 _ |a Duensing, Stefan
|b 36
773 _ _ |a 10.1038/s41598-018-35058-3
|g Vol. 8, no. 1, p. 16708
|0 PERI:(DE-600)2615211-3
|n 1
|p 16708
|t Scientific reports
|v 8
|y 2018
|x 2045-2322
909 C O |p VDB
|o oai:inrepo02.dkfz.de:141416
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)1042737c83ba70ec508bdd99f0096864
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)b2df3652dfa3e19d5e96dfc53f44a992
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)c420f6efccb409e1a287be027501a74c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-He78)abd768f879e71d08068d48fabb7e96cf
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 26
|6 P:(DE-He78)33c74005e1ce56f7025c4f6be15321b3
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 28
|6 P:(DE-He78)13a0afba029f5f64dc18b25ef7499558
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 29
|6 P:(DE-He78)5ca7e97b2769bb97f8c73431c6566b94
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 32
|6 P:(DE-He78)3d04c8fee58c9ab71f62ff80d06b6fec
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 34
|6 P:(DE-He78)ea098e4d78abeb63afaf8c25ec6d6d93
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 35
|6 P:(DE-He78)7483734fd8ab316391aa604c95f0e98a
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Functional and structural genomics
|x 0
914 1 _ |y 2018
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b SCI REP-UK : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l C060 Biostatistik
|x 0
920 1 _ |0 I:(DE-He78)E060-20160331
|k E060
|l E060 KKE Nuklearmedizin
|x 1
920 1 _ |0 I:(DE-He78)E010-20160331
|k E010
|l E010 Radiologie
|x 2
920 1 _ |0 I:(DE-He78)E132-20160331
|k E132
|l Medizinische Bildverarbeitung
|x 3
920 1 _ |0 I:(DE-He78)E230-20160331
|k E230
|l E230 Medizinische Bildverarbeitung
|x 4
920 1 _ |0 I:(DE-He78)B063-20160331
|k B063
|l B063 Krebsgenomforschung
|x 5
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 6
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a I:(DE-He78)E060-20160331
980 _ _ |a I:(DE-He78)E010-20160331
980 _ _ |a I:(DE-He78)E132-20160331
980 _ _ |a I:(DE-He78)E230-20160331
980 _ _ |a I:(DE-He78)B063-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21